Julian Teare
Imperial College London
H-index: 38
Europe-United Kingdom
Top articles of Julian Teare
Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib
Journal of Crohn's and Colitis
2023/11/6
181 ENDOBARRIER®, A DUODENAL-JEJUNAL BYPASS LINER DEVICE, ALTERS THE GLOBAL METABOLIC AND THE GUT BACTERIAL PROFILES OF PATIENTS WITH OBESITY AND DIABETES
Gastroenterology
2023/5/1
Sa1871 NETWORKS OF PATHOBIONTS IN THE TUMOUR MUCOSAL NICHE PREDICT SURVIVAL FOLLOWING COLORECTAL CANCER RESECTION
Gastroenterology
2023/5/1
Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide
Diabetes Care
2023/4/1
P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA. 4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK …
Journal of Crohn's and Colitis
2023/2/1
Infliximab and tofacitinib attenuate neutralizing antibody responses against SARS-CoV-2 ancestral and omicron variants in inflammatory bowel disease patients after 3 doses of …
Gastroenterology
2023/2/1
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients
EBioMedicine
2023/2/1
Neutralising antibody responses against SARS-CoV-2 Omicron BA. 4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine …
Eclinicalmedicine
2023/10/1
1708-P: Comparing 9-vs. 12-Month Implantation in the Worldwide EndoBarrier (EB) Registry
Diabetes
2023/6/20
Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer
Microbiome
2023/5/8
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre …
The Lancet Gastroenterology & Hepatology
2022/11/1
P2 COVID-19 vaccination response in immunosuppressed patients with IBD is associated with altered gut microbiota function
2022/6/1
1415-P: Risk–Benefit Data from the Worldwide EndoBarrier (EB) Registry
Diabetes
2022/6/1
Does bypass of the proximal small intestine impact food intake, preference, and taste function in humans? An experimental medicine study using the duodenal-jejunal bypass liner
Nutrients
2022/5/20
Su1611: POOR RESPONSE TO ANTI-SARS-COV-2 VACCINATION IN IMMUNOSUPPRESSED INFLAMMATORY BOWEL DISEASE PATIENTS IS ASSOCIATED WITH ALTERED GUT MICROBIOTA FUNCTION
Gastroenterology
2022/5
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
The lancet Gastroenterology & hepatology
2022/4/1
Duodenal-jejunal bypass liner for the management of type 2 diabetes mellitus and obesity: a multicenter randomized controlled trial
2022/3/1
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis
Journal for Immunotherapy of Cancer
2022
Enhanced Neoplasia Detection in Chronic ulcerative colitis: results of the ENDCaP-C Diagnostic accuracy study
medRxiv
2022/12/16
A case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose: mannitol ratio in coeliac and Crohn’s disease
BMC gastroenterology
2022/12
Julian Teare
H-Index: 22
Hutan Ashrafian
H-Index: 41